GoodRx and GEO Group Top Expectations, Outlook Miss
- August 09th, 2023
- 365 views
GoodRx Holdings, Inc. (Nasdaq: GDRX) revealed second-quarter 2023 adjusted earnings of $0.07 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales amounted to $189.70 million, slightly exceeding the analysts' projected revenue of $186.82 million. However, GoodRx anticipates Q3 revenue to range between approximately $186 million and $190 million, contrasting with the consensus estimate of $192.58 million for the period.
$GDRX was trading at $8.65 in pre-market, reflecting a decrease of $0.09 (-1.03%).
Shifting focus, The GEO Group, Inc. (NYSE: GEO) reported earnings of $0.24 per share for Q2 2023, surpassing the consensus EPS estimate of $0.20. The company's quarterly revenues reached $593.90 million, exceeding the analysts' expected revenue of $588.26 million. GEO Group projects full-year 2023 revenues around $2.4 billion, slightly below the consensus estimate of $2.43 billion for the period.
In pre-market, $GEO was trading at $7.02, down $0.26 (-3.57%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login